Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil + Propofol for Diagnostic Panendoscopy
NCT02093143Phase 3Completed
- Sponsor
- CHU de Besançon
- Start
- Jun 2009
- Primary completion
- Feb 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of remifentanil in head and neck cancer (HNC), sponsored by CHU de Besançon. Started Jun 2009; status: completed.
02
Drugs
remifentanil
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT02093143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02093143.